Append Medical is developing a novel transcatheter system for Left Atrial Appendage (LAA) elimination without implanting any device in the heart. This innovative approach aims to reduce stroke risks for patients with Non-Valvular Atrial Fibrillation (NVAF) by eradicating risks associated with Device Related Thromboembolism (DRT) and Peri Device Leakage (PDL). The system is designed to fit a wide range of anatomies and offers a fast, implant-free solution.